Investigating reproducible plastisol cannula fabrication

研究可重复的塑料溶胶插管制造

• 批准号: 530500-2018
• 负责人: Dalton, Colin
• 金额: $ 1.82万
• 依托单位: University of Calgary
• 依托单位国家: 加拿大
• 项目类别: Engage Grants Program
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-01-01 至 2019-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=648551
• 关键词: Investigating; reproducible; plastisol; cannula; fabrication

Elsius Biomedical Corp. is a Canadian medical device company located in Calgary that is developing a portable Cardiopulmonary Assist System (pCAS). The technology is based on Extracorporeal membrane oxygenation (ECMO). ECMO is a complex lifesaving technology that provides circulatory and respiratory support to very sick patients who are experiencing certain kinds of circulatory or respiratory failure. It requires a cannula to be inserted into the patient's body, which reroutes blood out of the patient into the pCAS system and then back into the body (usually via the femoral or jugular veins). It is difficult for Elsius to source small quantities of cannulas for validation testing of pCAS technology.This study will aid Elsius in developing their own in-house cannula fabrication knowledge.

Elsius Biomedical Corp. 是一家位于卡尔加里的加拿大医疗器械公司，正在开发便携式心肺辅助系统 (pCAS)。该技术基于体外膜肺氧合（ECMO）。 ECMO 是一项复杂的救生技术，可为患有某些循环或呼吸衰竭的重病患者提供循环和呼吸支持。它需要将插管插入患者体内，将患者的血液重新输送到 pCAS 系统中，然后返回体内（通常通过股静脉或颈静脉）。 Elsius 很难采购少量插管来进行 pCAS 技术的验证测试。这项研究将帮助 Elsius 发展自己的内部插管制造知识。